| 000 | 01772 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250517211218.0 | ||
| 264 | 0 | _c20190424 | |
| 008 | 201904s 0 0 eng d | ||
| 022 | _a2072-6805 | ||
| 024 | 7 |
_a10.3126/nepjoph.v9i2.19257 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKumari, Rashmi | |
| 245 | 0 | 0 |
_aTacrolimus versus Cyclosporine- Comparative Evaluation as First line drug in Vernal keratoconjuctivitis. _h[electronic resource] |
| 260 |
_bNepalese journal of ophthalmology : a biannual peer-reviewed academic journal of the Nepal Ophthalmic Society : NEPJOPH _c07 2017 |
||
| 300 |
_a128-135 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Randomized Controlled Trial | ||
| 650 | 0 | 4 | _aChild |
| 650 | 0 | 4 | _aChild, Preschool |
| 650 | 0 | 4 |
_aConjunctiva _xpathology |
| 650 | 0 | 4 |
_aConjunctivitis, Allergic _xdiagnosis |
| 650 | 0 | 4 |
_aCornea _xpathology |
| 650 | 0 | 4 |
_aCyclosporine _xadministration & dosage |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aDouble-Blind Method |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFollow-Up Studies |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunosuppressive Agents _xadministration & dosage |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aOintments |
| 650 | 0 | 4 | _aOphthalmic Solutions |
| 650 | 0 | 4 | _aProspective Studies |
| 650 | 0 | 4 | _aRecurrence |
| 650 | 0 | 4 |
_aTacrolimus _xadministration & dosage |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aSaha, Bhawesh Chandra | |
| 700 | 1 | _aSinha, Bibhuti Prasanna | |
| 700 | 1 | _aMohan, Nilesh | |
| 773 | 0 |
_tNepalese journal of ophthalmology : a biannual peer-reviewed academic journal of the Nepal Ophthalmic Society : NEPJOPH _gvol. 9 _gno. 18 _gp. 128-135 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.3126/nepjoph.v9i2.19257 _zAvailable from publisher's website |
| 999 |
_c28267057 _d28267057 |
||